New personalized genetic mouse model of Lesch-Nyhan syndrome for pharmacology and gene therapy

Authors

DOI:

https://doi.org/10.3897/rrpharmacology.4.32209

Abstract

Introduction: Lesch-Nyhan syndrome is a clinical and laboratory disorder caused by X-linked disruption of the purine metabolism. The deletion in the HPRT1 gene leads to the disappearance of valine in the eighth position of the protein amino acid sequence. The disease occurs in males and is accompanied by an excess of uric acid, urate nephropathy and neurologic impairment.

Objective of the Study: Generation of the new personalized genetic mouse model of Lesch-Nyhan syndrome for preclinical study of new approaches to the pharmacological and gene therapy

Materials and Methods: For genomic editing, the sequence was synthesized the sequence of the matrix GACCGGTCCCGTCATGCCGACACGCAGTCCCAGCGTGGTGAGCCAAGGGGACTCCAGCAGAGCCCCACAG was synthesized. For the cultivation of viable mouse embryos after microinjection, KSOM media was used. Amplification and sequencing was performed by the standard methods.

Results: A boy with not previously described hemizygous variant in the HPRT1 gene, was observed in our clinic. The mutation was the deletion of 8Val in the first exon of the HPRT1 gene. To introduce this mutation, we used the CRISPR-Cas9 genomic editing system. The genetic construct for microinjections included a mixture of the vector for the expression of Cas9 and sgRNA (px330), as well as the matrix for homologous recombination (ssODN), in a ratio of 1 part Cas9 to 3 parts of the ssODN matrix. Four of the 12 obtained animals were mosaic transgenes. One of 4 mice mated with a male from the hybrid strain CBA x C57BL/6, and descendants of F2 have already been received from this mating.

Discussion: During the creation of HPRT1 genetically modified mice, we encountered certain difficulties. First, from 615 transplanted embryos, only 12 were able to complete full embryonic development. 9 recipients we observed abortions in the later stages. These data may indicate possible violations of embryonic development in animals carrying a mutant copy of the HPRT1 gene.

Conclusion: In the current study, we present the results of the generation of a genetically modified mouse strain carrying a deletion in the HPRT1 gene. These mice can be effectively used for the preclinical testing of new drugs aimed at the treatment of Lesch-Nyhan syndrome.

Keywords:

transgenic mice, Lesch-Nyhan syndrome, CRISPR-Cas9, personalized medicine, orphane deases, CBAxC57BL/6

Author Contribution

Vladislav A. Kalmykov, Institute of Gene Biology of the Russian Academy of Sciences

Post-graduate student. Methodology, Formal analysis, Investigation, Review and editing. Visualization.

Pavel A. Kusov, Skolkovo institute of science and technology

Post-graduate student. Methodology, Formal analysis, Investigation, Original draft of paper, Review and editing, Visualization.

Maria I. Yablonskaia, Research and Clinical Institute for Pediatrics named after Academician Yuri Veltischev of the Pirogov Russian National Research Medical University of the Russian Ministry of Health

PhD in Medicine. Conceptualization, Formal analysis, Original draft of paper.

Evgeniy N. Korshunov, Institute of Gene Biology of the Russian Academy of Sciences

Post-graduate student. Investigation, Review and editing.

Diana S. Korshunova, Institute of Gene Biology of the Russian Academy of Sciences

Post-graduate student. Investigation, Review and editing.

Marina V. Kubekina, Institute of Gene Biology of the Russian Academy of Sciences

Post-graduate student. Methodology, Formal analysis, Review and editing of paper.

Yuliya Yu. Silaeva, Institute of Gene Biology of the Russian Academy of Sciences

PhD in Biology. Methodology, Original draft of paper, Review and editing, Visualization.

Alexey V. Deykin, Institute of Gene Biology of the Russian Academy of Sciences, Institute of General Pathology and Pathophysiology of the Russian Academy of Medical Sciences

PhD in Biology, Institute of General Pathology and Pathophysiology  Conceptualization, Methodology, Formal analysis, Investigation, Original draft of paper, review and editing, Supervision. Scopus

Nikolay E. Lukyanov, Yaroslavl State Medical University

MD. Investigation, Review and editing.

Downloads

Published

21-12-2018

How to Cite

Kalmykov VA, Kusov PA, Yablonskaia MI, Korshunov EN, Korshunova DS, Kubekina MV, Silaeva YY, Deykin AV, Lukyanov NE (2018) New personalized genetic mouse model of Lesch-Nyhan syndrome for pharmacology and gene therapy. Research Results in Pharmacology 4(4): 115–122. https://doi.org/10.3897/rrpharmacology.4.32209

Issue

Section

Review article

Most read articles by the same author(s)